CGEM RSI Chart
Last 7 days
-10.2%
Last 30 days
58.1%
Last 90 days
48.8%
Trailing 12 Months
165.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 |
2022 | 0 | 173.6M | 140.5M | 107.4M |
2021 | 0 | 0 | 0 | 18.9M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 07, 2024 | michaelson jennifer | sold | -168,516 | 30.06 | -5,606 | chief scientific officer |
May 07, 2024 | michaelson jennifer | acquired | 24,105 | 4.3 | 5,606 | chief scientific officer |
May 06, 2024 | michaelson jennifer | sold | -1,628,160 | 28.0717 | -58,000 | chief scientific officer |
May 06, 2024 | michaelson jennifer | acquired | 215,000 | 4.3 | 50,000 | chief scientific officer |
Feb 22, 2024 | jones jeffrey alan | acquired | - | - | 62,500 | chief medical officer |
Feb 22, 2024 | savill corrine | acquired | - | - | 37,500 | chief business officer |
Feb 22, 2024 | michaelson jennifer | acquired | - | - | 50,000 | chief scientific officer |
Feb 22, 2024 | sumer jacquelyn l | acquired | - | - | 50,000 | chief legal officer |
Feb 22, 2024 | ahmed nadim | acquired | - | - | 160,000 | president and ceo |
Feb 22, 2024 | trigilio jeffrey | acquired | - | - | 50,000 | chief financial officer |
Which funds bought or sold CGEM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 13, 2024 | HARBOR CAPITAL ADVISORS, INC. | reduced | -13.3 | 66,622 | 214,000 | 0.03% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | added | 3.3 | 4,861,620 | 11,543,700 | -% |
May 13, 2024 | FMR LLC | added | 19.00 | 4,459 | 8,963 | -% |
May 13, 2024 | Jump Financial, LLC | new | - | 369,598 | 369,598 | 0.01% |
May 13, 2024 | UBS Group AG | added | 18.44 | 1,406,710 | 2,841,250 | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | added | 21.59 | 2,781,000 | 5,472,000 | 0.01% |
May 13, 2024 | Nuveen Asset Management, LLC | added | 5.55 | 688,491 | 1,588,500 | -% |
May 13, 2024 | Rafferty Asset Management, LLC | new | - | 1,653,820 | 1,653,820 | 0.01% |
May 13, 2024 | Ameritas Investment Partners, Inc. | added | 31.00 | 24,070 | 44,287 | -% |
May 13, 2024 | FIRST TRUST ADVISORS LP | added | 3.12 | 685,541 | 1,631,940 | -% |
Unveiling Cullinan Management, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Cullinan Management, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 49.2B | 6.8B | -8.24 | 7.18 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.7B | 2.0B | -56.37 | 9.34 | ||||
BMRN | 15.1B | 2.5B | 73.61 | 6.12 | ||||
INCY | 12.8B | 3.8B | 17.19 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.4B | 107.9M | -9.91 | 48.09 | ||||
APLS | 5.0B | 524.1M | -11.98 | 9.54 | ||||
AXSM | 3.7B | 251.0M | -12.39 | 14.63 | ||||
ARWR | 2.8B | 240.7M | -6.04 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.4K | 3.02 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.9B | 996.6M | -4.75 | 1.9 | ||||
CRBP | 456.3M | 881.7K | -13.52 | 481.06 | ||||
INO | 297.2M | 4.9M | -2.38 | 61.07 | ||||
IBIO | 16.2M | 2.1M | -0.7 | 7.61 |
Cullinan Management, Inc. News
Income Statement (Quarterly) | |||||||||
Description | (%) Q/Q | 2023Q4 | 2022Q4 | 2022Q3 | 2022Q2 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 |
Revenue | - | - | - | - | 174 | - | - | - | 19.00 |
Operating Expenses | 39.5% | 45.00 | 33.00 | 30.00 | 37.00 | 34.00 | 18.00 | 17.00 | 18.00 |
S&GA Expenses | -5.8% | 11.00 | 11.00 | 10.00 | 11.00 | 13.00 | 6.00 | 5.00 | 5.00 |
R&D Expenses | 63.4% | 35.00 | 21.00 | 20.00 | 26.00 | 21.00 | 13.00 | 12.00 | 12.00 |
EBITDA Margin | -211.5% | -1.57* | 1.41* | 1.04* | 0.89* | -3.56* | - | - | - |
Income Taxes | -651.2% | -14.12 | -1.88 | -2.50 | 66.00 | - | - | - | - |
Earnings Before Taxes | -37.1% | -39.68 | -28.95 | -27.41 | 240 | -34.21 | -18.26 | -16.44 | 1.00 |
EBT Margin | -211.8% | -1.58* | 1.41* | 1.04* | 0.89* | -3.56* | - | - | - |
Net Income | -Infinity% | -23.71 | - | -24.80 | 174 | -32.86 | -17.35 | -16.44 | 1.00 |
Net Income Margin | -238.8% | -1.43* | 1.03* | 0.74* | 0.64* | -3.44* | - | - | - |
Free Cashflow | 29.9% | -18.13 | -25.86 | -54.60 | -25.42 | -15.17 | -10.55 | -16.19 | -1.51 |
Balance Sheet | ||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Assets | -2.1% | 484 | 495 | 522 | 515 | 561 | 617 | 667 | 437 | 437 | 453 | 464 | 480 | 215 |
Current Assets | 0.7% | 480 | 477 | 498 | 399 | 474 | 582 | 623 | 322 | 297 | 329 | 344 | 447 | 212 |
Cash Equivalents | 51.8% | 98.00 | 65.00 | 142 | 122 | 156 | 243 | 354 | 76.00 | 60.00 | 88.00 | 124 | 294 | 168 |
Net PPE | -7.2% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | 17.0% | 30.00 | 26.00 | 22.00 | 29.00 | 26.00 | 31.00 | 63.00 | 18.00 | 12.00 | 8.00 | 6.00 | 10.00 | 14.00 |
Current Liabilities | 20.0% | 28.00 | 23.00 | 20.00 | 26.00 | 22.00 | 27.00 | 62.00 | 17.00 | 12.00 | 8.00 | 6.00 | 10.00 | 14.00 |
Long Term Debt | 1042.9% | 2.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -3.2% | 454 | 469 | 500 | 486 | 535 | 586 | 605 | 419 | 425 | 445 | 459 | 470 | 200 |
Retained Earnings | -13.4% | -200 | -177 | -137 | -105 | -47.69 | -20.91 | 4.00 | -171 | -158 | -126 | -109 | -93.41 | -93.34 |
Additional Paid-In Capital | 1.2% | 655 | 647 | 639 | 593 | 585 | 611 | 604 | 593 | 585 | 570 | 565 | 560 | 292 |
Shares Outstanding | 0.3% | 43.00 | 43.00 | 43.00 | 39.00 | 46.00 | 46.00 | 45.00 | 44.00 | 44.00 | 43.00 | 43.00 | 42.00 | - |
Minority Interest | - | 0.00 | - | - | - | - | - | 0.00 | 1.00 | 0.00 | 2.00 | 3.00 | 3.00 | 1.00 |
Float | - | - | - | 374 | - | - | - | 376 | - | - | - | 717 | - | - |
Cashflow (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 |
Cashflow From Operations | 46.9% | -18.13 | -34.14 | -31.01 | -51.00 | -24.98 | -54.35 | -25.42 | -21.91 | -15.17 | -10.55 | -16.20 | -1.51 | -9.44 | -9.07 | -6.25 | -5.01 |
Share Based Compensation | -2.9% | 8.00 | 8.00 | 8.00 | 7.00 | - | 5.00 | 9.00 | 7.00 | 12.00 | 5.00 | 4.00 | 4.00 | - | - | - | - |
Cashflow From Investing | 219.8% | 51.00 | -42.96 | 12.00 | 15.00 | -28.61 | -57.98 | 301 | 35.00 | -15.86 | -25.59 | -154 | -137 | 11.00 | -1.94 | 12.00 | -26.89 |
Cashflow From Financing | 121.4% | 0.00 | 0.00 | 39.00 | 2.00 | -32.91 | 1.00 | 2.00 | 4.00 | 3.00 | 1.00 | 1.00 | 265 | 125 | 1.00 | - | 14.00 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.00 | - | - | 0.00 |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating expenses: | ||
Research and development | $ 148,156 | $ 91,948 |
General and administrative | 42,493 | 40,189 |
Total operating expenses | 190,649 | 132,137 |
Impairment of long-lived assets | 440 | 0 |
Gain on sale of Cullinan Pearl | 0 | 276,785 |
Income (loss) from operations | (191,089) | 144,648 |
Other income (expense): | ||
Interest income | 21,627 | 6,611 |
Other income (expense), net | 239 | 57 |
Net income (loss) before income taxes | (169,223) | 151,316 |
Income tax expense (benefit) | (14,122) | 42,121 |
Net income (loss) | (155,101) | 109,195 |
Net loss attributable to noncontrolling interests | (1,939) | (2,019) |
Net income (loss) attributable to common stockholders of Cullinan | (153,162) | 111,214 |
Comprehensive income (loss): | ||
Net income (loss) | (155,101) | 109,195 |
Unrealized gain (loss) on investments | 2,472 | (1,763) |
Comprehensive income (loss) | (152,629) | 107,432 |
Comprehensive loss attributable to noncontrolling interests | (1,939) | (2,019) |
Comprehensive income (loss) attributable to Cullinan | $ (150,690) | $ 109,451 |
Net income (loss) per share attributable to common stockholders of Cullinan: | ||
Basic | $ (3.69) | $ 2.46 |
Diluted | $ (3.69) | $ 2.38 |
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders of Cullinan: | ||
Basic | 41,550 | 45,164 |
Diluted | 41,550 | 46,640 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 98,434 | $ 156,152 |
Short-term investments | 368,633 | 311,140 |
Prepaid expenses and other current assets | 13,124 | 7,180 |
Total current assets | 480,191 | 474,472 |
Property and equipment, net | 989 | 1,174 |
Operating lease right-of-use assets | 2,543 | 4,130 |
Other assets | 459 | 459 |
Long-term investments | 0 | 80,882 |
Total assets | 484,182 | 561,117 |
Current liabilities: | ||
Accounts payable | 2,493 | 2,660 |
Accrued expenses and other current liabilities | 24,204 | 14,135 |
Income tax payable | 0 | 4,282 |
Operating lease liabilities, current | 1,440 | 1,421 |
Total current liabilities | 28,137 | 22,498 |
Long-term liabilities: | ||
Lease liabilities, non-current | 2,150 | 3,590 |
Total liabilities | 30,287 | 26,088 |
Commitments and contingencies (Note 12) | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value, 10,000,000 shares authorized as of December 31, 2023 and 2022; 647,500 and no shares issued and outstanding as of December 31, 2023 and 2022, respectively. | 0 | 0 |
Common stock, $0.0001 par value, 150,000,000 shares authorized as of December 31, 2023 and 2022; 42,900,083 and 45,796,449 shares issued and outstanding as of December 31, 2023 and 2022, respectively. | 4 | 5 |
Additional paid-in capital | 654,685 | 585,320 |
Accumulated other comprehensive loss | (129) | (2,601) |
Accumulated deficit | (200,857) | (47,695) |
Total Cullinan stockholders' equity | 453,703 | 535,029 |
Noncontrolling interests | 192 | 0 |
Total stockholders' equity | 453,895 | 535,029 |
Total liabilities and stockholders' equity | $ 484,182 | $ 561,117 |